The treatment, made by the biotech company Regeneron, is a cocktail of two powerful antibodies that have shown promise for people who get it early in the course of the disease. By Katie Thomas and Noah Weiland from NYT Health https://ift.tt/3fkqXKY
The treatment, made by the biotech company Regeneron, is a cocktail of two powerful antibodies that have shown promise for people who get it early in the course of the disease. By Katie Thomas and Noah Weiland from NYT Health https://ift.tt/3fkqXKY